InventionMed S.A. (WSE:INM)
0.1080
-0.0010 (-0.92%)
At close: Sep 4, 2026
InventionMed Revenue
InventionMed had revenue of 729.97K PLN in the quarter ending June 30, 2026, a decrease of -53.69%. This brings the company's revenue in the last twelve months to 2.90M, up 44.33% year-over-year. In the year 2025, InventionMed had annual revenue of 3.17M with 1,041.56% growth.
Revenue (ttm)
2.90M
Revenue Growth
+44.33%
P/S Ratio
7.56
Revenue / Employee
579.33K
Employees
5
Market Cap
21.90M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.17M | 2.89M | 1,041.56% |
| Dec 31, 2024 | 277.76K | 277.16K | 45,810.74% |
| Dec 31, 2023 | 605.00 | -3.46K | -85.12% |
| Dec 31, 2022 | 4.07K | -6.39K | -61.10% |
| Dec 31, 2021 | 10.45K | 5.25K | 100.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Synektik Spólka Akcyjna | 932.97M |
| Medicalgorithmics | 34.45M |
| Nestmedic | 795.19K |
| Zortrax | 723.51K |
| Adiuvo Investments | 431.00K |
| Genomtec | 30.00K |
| Medinice | 19.00K |
| Milton Essex Spólka Akcyjna | 425.00 |